Terns Pharmaceuticals Inc (TERN)
EBITDA Growth
-57.65%
Quarterly · Period ending:
TERN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-57.65%period ending
Latest reported-57.65%period ending
TERN Quarterly EBITDA YoY % (10.01% → -57.65%)
Year-over-year change
High-resolution chart · PNG
TERN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -57.6514% | |
| -12.9215% | |
| -6.6236% | |
| -7.3094% | |
| -3.8313% | |
| 26.4862% | |
| -27.4209% | |
| -3.7372% | |
| -35.8785% | |
| -78.1154% | |
| -28.9418% | |
| -57.6815% | |
| -11.4753% | |
| -41.399% | |
| -28.76% | |
| -2.6669% | |
| -58.1505% | |
| -35.572% | |
| -6.0712% | |
| -40.5892% | |
| 10.0052% |